PIN6 COST-ANALYSIS OF LEVOFLOXACIN IV COMPARED TO OTHER GUIDELINE-ENDORSED THERAPIES FOR PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA

May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72915-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)72915-6/fulltext
Section Title :
Section Order : 486
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72915-6&doi=10.1016/S1098-3015(10)72915-6
HEOR Topics :
Tags :
Regions :